Evidence map›Paper›PMID 32024729›Full record

ArticleJournal of clinical microbiology2020

Evaluation of Serum Cryptococcal Antigen Testing Using Two Novel Semiquantitative Lateral Flow Assays in Persons with Cryptococcal Antigenemia.

Caleb Skipper, Kiiza Tadeo, Emily Martyn, Elizabeth Nalintya, Radha Rajasingham, David B Meya, Bosco Kafufu, Joshua Rhein, David R Boulware

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. False-Positive IMMYJournal of fungi (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Cryptococcal meningitis.Nature reviews. Disease primers · 2023
    Review
  12. Cryptococcus neoformans, a global threat to human health.Infectious diseases of poverty · 2023
    Review
  13. Article
  14. Cryptococcal andOpen forum infectious diseases · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Infections due to RareJournal of fungi (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Caleb SkipperInfectious Diseases Institute, Makerere University, Kampala, Uganda skipp015@umn.edu.
Kiiza TadeoInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Emily MartynInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Elizabeth NalintyaInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Radha RajasinghamUniversity of Minnesota, Minneapolis, Minnesota, USA.
David B MeyaInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Bosco KafufuInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Joshua RheinInfectious Diseases Institute, Makerere University, Kampala, Uganda.
David R BoulwareUniversity of Minnesota, Minneapolis, Minnesota, USA.
Makerere University · UGInfectious Diseases Institute · UGUniversity of Minnesota · US

Funding

NPGH LEADERs YR12: OBSSR (Greenberg, Ngwafong Mukere) & NIBIB (Lee)D43TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI Dibyadyuti Datta, Chandy C. John · 2017 to 2026
$15.2M
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related MeningitisR01NS086312 · NINDS · UNIVERSITY OF MINNESOTA · PI David R Boulware, David Bisagaya Meya · 2013 to 2026
$8.3M
Trial for the Optimal Timing of HIV Therapy after Cryptococcal MeningitisU01AI089244 · NIAID · UNIVERSITY OF MINNESOTA · PI BOULWARE, DAVID R · 2010 to 2014
$7.6M
Infectious Disease Training in Clinical InvestigationT32AI055433 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI David R Boulware · 2003 to 2026
$6.1M
Northern/Pacific Universities Global Health Research Training ConsortiumR25TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI KOLARS, JOSEPH C., NERURKAR, VIVEK RAMCHANDRA · 2012 to 2016
$5.9M
Evaluation of CRAG screening with enhanced antifungal therapy for asymptomatic CRAG-positive personsK23AI138851 · NIAID · UNIVERSITY OF MINNESOTA · PI RAJASINGHAM, RADHA · 2018 to 2022
$954k
Improving Outcomes of HIV-Associated Cryptococcosis in Resource-Limited SettingsK01TW010268 · FIC · UNIVERSITY OF MINNESOTA · PI RHEIN, JOSHUA R · 2016 to 2020
$703k
FIC NIH HHS D43 TW009345FIC NIH HHS K01 TW010268FIC NIH HHS R25 TW009345NIAID NIH HHS K23 AI138851NIAID NIH HHS T32 AI055433NIAID NIH HHS U01 AI089244NINDS NIH HHS R01 NS086312
6 · The paper itself

Abstract

Early cryptococcal disease can be detected via circulating antigen in blood before fulminant meningitis develops, when early antifungal therapy improves survival. Two semiquantitative cryptococcal antigen (CrAg) lateral flow assays (LFAs) have been developed, but their diagnostic performance has not been defined. Cryopreserved serum samples from HIV-infected Ugandans obtained as part of a prospective CrAg-screening cohort were tested in duplicate for CrAg by the CrAgSQ (IMMY) and CryptoPS (Biosynex) lateral flow assays. Case-controlled diagnostic performance was measured using the FDA-approved CrAg LFA (IMMY) as a reference standard via McNemar's test. Of 99 serum samples tested, 57 were CrAg positive (CrAg

Indexed as

CryptococcusHIV InfectionsMeningitis, CryptococcalAntigens, FungalCD4 Lymphocyte CountHumansProspective StudiesSensitivity and SpecificityAntigens, FungalCrAgCrAg positivecryptococcal antigencryptococcal antigenemiacryptococcal meningitisCryptococcusCryptococcus neoformansHIVhuman immunodeficiency virus

Identifiers

PMID32024729
PMCPMC7098738
OpenAlexW3004460481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.